Predictive and Prognostic Value of Non-Coding RNA in Breast Cancer

Cancers (Basel). 2022 Jun 15;14(12):2952. doi: 10.3390/cancers14122952.

Abstract

For decades since the central dogma, cancer biology research has been focusing on the involvement of genes encoding proteins. It has been not until more recent times that a new molecular class has been discovered, named non-coding RNA (ncRNA), which has been shown to play crucial roles in shaping the activity of cells. An extraordinary number of studies has shown that ncRNAs represent an extensive and prevalent group of RNAs, including both oncogenic or tumor suppressive molecules. Henceforth, various clinical trials involving ncRNAs as extraordinary biomarkers or therapies have started to emerge. In this review, we will focus on the prognostic and diagnostic role of ncRNAs for breast cancer.

Keywords: biomarkers; breast cancer; diagnostic; non-coding RNA; prognostic.

Publication types

  • Review

Grant support

This research received no external funding.